ATE455187T1 - Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel - Google Patents

Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel

Info

Publication number
ATE455187T1
ATE455187T1 AT02741410T AT02741410T ATE455187T1 AT E455187 T1 ATE455187 T1 AT E455187T1 AT 02741410 T AT02741410 T AT 02741410T AT 02741410 T AT02741410 T AT 02741410T AT E455187 T1 ATE455187 T1 AT E455187T1
Authority
AT
Austria
Prior art keywords
anticancer agent
fragments
genes
gene
tumor
Prior art date
Application number
AT02741410T
Other languages
English (en)
Inventor
Teiji Takechi
Katsuhisa Koizumi
Atsushi Azuma
Masakazu Fukushima
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE455187T1 publication Critical patent/ATE455187T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02741410T 2001-07-05 2002-07-03 Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel ATE455187T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001204448 2001-07-05
JP2001239181 2001-08-07
PCT/JP2002/006754 WO2003004640A1 (en) 2001-07-05 2002-07-03 Dna arrays for measuring sensitivity to anticancer agent

Publications (1)

Publication Number Publication Date
ATE455187T1 true ATE455187T1 (de) 2010-01-15

Family

ID=26618186

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02741410T ATE455187T1 (de) 2001-07-05 2002-07-03 Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel

Country Status (6)

Country Link
US (1) US20040265813A1 (de)
EP (1) EP1411120B1 (de)
JP (1) JPWO2003004640A1 (de)
AT (1) ATE455187T1 (de)
DE (1) DE60235088D1 (de)
WO (1) WO2003004640A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297553B2 (en) 2002-05-28 2007-11-20 Nanosphere, Inc. Method for attachment of silylated molecules to glass surfaces
AU2002322458A1 (en) 2001-07-13 2003-01-29 Nanosphere, Inc. Method for immobilizing molecules onto surfaces
CA2494262A1 (en) * 2002-07-31 2004-02-05 University Of Southern California Polymorphisms for predicting disease and treatment outcome
CN1761665A (zh) 2003-03-14 2006-04-19 大鹏药品工业株式会社 抗肿瘤效果增强剂和抗肿瘤剂
WO2005012875A2 (en) * 2003-07-29 2005-02-10 Bristol-Myers Squibb Company Biomarkers of cyclin-dependent kinase modulation
JP2006042802A (ja) * 2004-06-28 2006-02-16 Sumitomo Chemical Co Ltd コモンマーモセット由来のヒポキサンチングアニンホスホリボシルトランスフェラーゼ遺伝子及びその利用
US20060115827A1 (en) * 2004-07-01 2006-06-01 University Of Southern California Genetic markers for predicting disease and treatment outcome
CN101155600B (zh) * 2005-04-01 2011-05-04 大鹏药品工业株式会社 放射线治疗增强剂
KR101135789B1 (ko) * 2005-04-01 2012-04-16 다이호야쿠힌고교 가부시키가이샤 피리딘 유도체를 유효성분으로 하는 방사선 치료 증강제
WO2006132982A2 (en) * 2005-06-03 2006-12-14 Aviaradx, Inc. Normalization genes
CN103424541B (zh) * 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
JP5413818B2 (ja) * 2007-03-29 2014-02-12 国立大学法人佐賀大学 蛍光多重染色による蛋白定量法
WO2010045318A2 (en) * 2008-10-14 2010-04-22 Caris Mpi, Inc. Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
EP3722810A3 (de) * 2009-02-11 2021-01-13 Caris MPI, Inc. Molekulare profilierung von tumoren
NZ593272A (en) * 2011-06-07 2013-02-22 Scott Pearson Breathing pipe with compartment having moutpiece and fan drivingly connected to a fan in another separated compartment to force air with active substance to outlet, typically near users nose to avoid nuisance to others
JPWO2016121715A1 (ja) * 2015-01-26 2017-11-02 国立大学法人名古屋大学 肺がん患者の予後を評価するための情報を提供する方法、肺がん患者の予後予測方法、内部標準、抗体、肺がん患者の予後予測装置、予後予測装置のプログラム及び記録媒体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US6025194A (en) * 1997-11-19 2000-02-15 Geron Corporation Nucleic acid sequence of senescence asssociated gene
US9534254B1 (en) * 1999-02-02 2017-01-03 Abbott Molecular Inc. Patient stratification for cancer therapy based on genomic DNA microarray analysis
WO2001032928A2 (en) * 1999-11-05 2001-05-10 Phase-1 Molecular Toxicology Methods of determining individual hypersensitivity to an agent

Also Published As

Publication number Publication date
EP1411120A1 (de) 2004-04-21
WO2003004640A1 (en) 2003-01-16
DE60235088D1 (de) 2010-03-04
JPWO2003004640A1 (ja) 2004-10-28
EP1411120B1 (de) 2010-01-13
EP1411120A4 (de) 2006-09-06
US20040265813A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
ATE455187T1 (de) Dna-arrays zur messung der empfindlichkeit gegenüber einem antikrebsmittel
Burmistrova et al. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11)
Redon et al. Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer
JP2019526257A5 (de)
WO2002079411A3 (en) Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification
CA3077750C (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
JP5769952B2 (ja) Ｅｍｌ４−ａｌｋ融合遺伝子の高感度検出方法
KR102202726B1 (ko) 편평상피세포암의 진단 또는 예후 예측용 마커 및 이의 용도
Wong et al. Identification of novel microRNAs in the sheep heart and their regulation in heart failure
CN111944809A (zh) 帕金森病的诊断标志物及其应用
AU7286187A (en) Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells
WO2001092538A1 (en) Method of detecting and quantifying human p450 molecular species and probe and kit for this method
CN112921098B (zh) 一种用于三阴性乳腺癌检测的标志物及其检测试剂和应用
CN110820051A (zh) 一种高灵敏度融合基因检测方法及其应用
CN107177676A (zh) 长链非编码rna nonhsat113026用于肾癌诊断分子标志物的用途
CN102534042A (zh) 一种多重竞争性pcr定量基因表达谱分析方法
CN111979315A (zh) 环状tp63作为肺鳞癌诊断或治疗靶点的应用
CN109735622A (zh) 与结直肠癌相关的lncRNA及其应用
CN109652529A (zh) 骨质疏松特异性miRNA、组合物及其诊疗用途
CN109628594A (zh) 一种与肝癌相关的长链非编码rna及其应用
EP3321377B1 (de) Verfahren zur bestimmung der empfindlichkeit auf simultanen inhibitor gegen parp und tankyrase
KR102289481B1 (ko) Parp1 저해제 내성 암의 진단를 위한 조성물, 키트 및 방법
CN107312851A (zh) 心肌梗死生物标志物miR‑1283
CN108165546A (zh) 一种miRNA生物标志物、组合物及其用途
CN102094070A (zh) HER2过量表达的mRNA原位杂交检测试剂盒

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties